F.WilfordGerminoMD

PubMed

• 28 citations
  History and Justification of a National Blood Pressure Measurement Validated Device Listing.
  Jordana B. Cohen, Raj Padwal, Michael Gutkin, Beverly B. Green, Michael J. Bloch, F. Wilford Germino, Domenic A. Sica, Anthony J. Viera, Benjamin M. Bluml, William B. ...> ;Hypertension. 2019 Feb 1
• Unmasking Masked Hypertension
  F. Wilford Germino> ;Journal of Clinical Hypertension. 2014 Apr 1
• 4 citations
  Therapeutic inertia and measurement inertia in hypertension: a call to action.
  F. Wilford Germino> ;Journal of Clinical Hypertension. 2013 Jun 1
• 1 citations
  Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring
  Steven G. Chrysant, F. Wilford Germino, Joel M. Neutel> ;American Journal of Cardiovascular Drugs. 2012 Dec 29
• 8 citations
  Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I–II hypertension:
  F. Wilford Germino, Yuhua Lin, Vojislav Pejovic, Lynn Bowen> ;Therapeutic Advances in Cardiovascular Disease. 2012 Sep 24
• 2 citations
  Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated...
  F. Wilford Germino, Joel M. Neutel, Robert Dubiel, Jen-Fue Maa, Kathleen J. Chavanu> ;American Journal of Cardiovascular Drugs. 2012 Dec 12
• 1 citations
  Which diuretic is the preferred agent for treating essential hypertension: hydrochlorothiazide or chlorthalidone?
  F. Wilford Germino> ;Current Cardiology Reports. 2012 Aug 24
• 23 citations
  Noninsulin Treatment of Type 2 Diabetes Mellitus in Geriatric Patients: A Review
  F. Wilford Germino> ;Clinical Therapeutics. 2011 Dec 1
• 1 citations
  Efficacy and safety of olmesartan medoxomil in patients with stage 1 hypertension: blood pressure lowering and goal achievement.
  F. Wilford Germino> ;Postgraduate Medicine. 2010 Nov 1
• 13 citations
  The impact of lactotripeptides on blood pressure response in stage 1 and stage 2 hypertensives.
  F. Wilford Germino, Joel M. Neutel, Mako Nonaka, Sheldon S. Hendler> ;Journal of Clinical Hypertension. 2010 Mar 1
• 3 citations
  Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomiz...
  F. Wilford Germino> ;Clinical Therapeutics. 2009 Sep 1
• 2 citations
  JNC 8: expectations, challenges, and wishes--a primary care perspective.
  F. Wilford Germino> ;Journal of Clinical Hypertension. 2009 Oct 1
• 16 citations
  The Management and Treatment of Hypertension
  F. Wilford Germino> ;Clinical Cornerstone. 2009 Jan 1
• 7 citations
  Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
  Joel M. Neutel, F. Wilford Germino, David J. Smith> ;Journal of the Renin-Angiotensin-Aldosterone System. 2005 Jun 1
• 18 citations
  A Comparison of the Cough Profile of Fosinopril and Enalapril in Hypertensive Patients with a History of ACE Inhibitor-Associated Cough.
  Daniel David, Nader S. Jallad, F. Wilford Germino, Michael S. Willett, Jacqueline de Silva, Susan M. Weidner, Donna J. Mills> ;American Journal of Therapeutics. 1995 Oct 1
• The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.
  Glasser, S. P., DiBianco, R., Effron, B. A., Faas, F., Germino, F. W., Shane, L. E., Unger, A. H., Staggers, J. E.> ;Am J Cardiol. 1996 Jan 1
• Latest clinical developments in the diagnosis and treatment of hypertension. Introduction.
  Germino, F. W.> ;Clin Cornerstone. 2009 Jan 01
• Join now to see all